Dignitana selected as Scalp Cooling Provider by Nuffield Health in UK

Next generation DigniCap Delta device minimizes hair loss from chemotherapy

Dignitana AB today announces a partnership with Nuffield Health in the United Kingdom to provide DigniCap scalp cooling to minimize hair loss from chemotherapy. As the largest healthcare charity in the United Kingdom, Nuffield Health operates 31 hospitals and will initially provide DigniCap at North Staffordshire in Newcastle-under-Lyme and Wolverhampton Hospital in West Midlands, expanding to other Nuffield hospitals in the future.

“We are delighted to work with Nuffield in bringing the next generation in scalp cooling technology to their patients,” said William Cronin, Chief Executive Officer of Dignitana AB.  “Hair loss is a critical quality of life issue for so many cancer patients. The next generation DigniCap Delta is designed to optimize results and provide significant improvements in the patient experience. The dedicated team at Nuffield shares our commitment to these values and is eager to provide patients with access to this cutting-edge technology.”

Sweden-based Dignitana is the world leader in scalp cooling innovation providing the DigniCap Scalp Cooling System in 38 countries around the globe. The CE-marked DigniCap Scalp Cooling System demonstrated a success rate of 66 percent in the pivotal trial for FDA clearance in 2015. The new DigniCap Delta device was introduced in 2019.

Investor Relations

Melissa Bourestom, VP Corporate Communications  +1 469 518 5031 investorrelations@dignitana.com

About Dignitana

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001.  Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Learn more at www.dignitana.se and www.dignicap.comEric Penser Bank AB, Certified Adviser, Box 7405,103 91 Stockholm Phone: +46 8-463 83 00 certifiedadviser@penser.se www.penser.se